{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:27:56Z","timestamp":1794738476019,"version":"4.9.1"},"reference-count":42,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T00:00:00Z","timestamp":1226361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Population\u2010based plasmacytoma incidence and survival data are sparse. We analyzed incidence rates (IRs), IR ratios (IRRs), and 5\u2010year relative survival for plasmacytoma overall and by site \u2013 bone (P\u2010bone) and extramedullary (P\u2010extramedullary) \u2013 in the Surveillance, Epidemiology and End Results (SEER) Program (1992\u20132004). For comparison, we included cases of multiple myeloma (MM) diagnosed over the same time period in SEER. Incidence of MM (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200323\u2003544; IR 5\u00b735\/100\u2003000 person\u2010years) was 16\u2010times higher than plasmacytoma overall (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u20031543; IR\u2003=\u20030\u00b734), and incidence of P\u2010bone was 40% higher than P\u2010extramedullary (\n                    <jats:italic>P\u2003<\/jats:italic>\n                    &lt;\n                    <jats:italic>\u2003<\/jats:italic>\n                    0\u00b70001). The male\u2010to\u2010female IRRs for P\u2010bone, P\u2010extramedullary, and MM were 2\u00b70, 2\u00b76, and 1\u00b75, respectively. For plasmacytoma and MM, IRs were highest in Blacks, intermediate in Whites, and lowest in Asian\/Pacific Islanders. Compared with Whites, the Black IR was \u223c30% higher for P\u2010extramedullary and P\u2010bone and 120% higher for MM. IRs for all neoplasms increased exponentially with advancing age, less prominently at older ages for plasmacytoma than MM. Distinct age, gender, and race incidence patterns of plasma cell disorders suggest underlying differences in clinical detection, susceptibility, disease biology and\/or aetiological heterogeneity. Five\u2010year relative survival for P\u2010bone, P\u2010extramedullary, and MM varied significantly by age (&lt;60\/60+ years), supporting age\u2010related differences in disease burden at presentation, disease biology, and\/or treatment approaches.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07421.x","type":"journal-article","created":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T19:35:16Z","timestamp":1226432116000},"page":"86-94","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":224,"title":["Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992\u20132004"],"prefix":"10.1111","volume":"144","author":[{"given":"Gra\u00e7a M.","family":"Dores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"McGlynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle E.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha S.","family":"Linet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Devesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,12,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810801)48:3<845::AID-CNCR2820480330>3.0.CO;2-E"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12005"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)00334-3"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-104984"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00364.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2307\/2531329"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.11.1811"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2005.00804.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/141.4.300"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.6.2037"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015784"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(89)90008-4"},{"key":"e_1_2_6_15_1","volume-title":"International Classification of Diseases for Oncology","author":"Fritz A.","year":"2000"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059285"},{"key":"e_1_2_6_17_1","first-page":"47","article-title":"Clinical outcome of extramedullary plasmacytoma","volume":"85","author":"Galieni P.","year":"2000","journal-title":"Haematologica"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-006-0030-x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(90)90235-L"},{"key":"e_1_2_6_22_1","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe E.S.","year":"2001"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-118"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.4.255"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.0100"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116129"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30348-4"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3449"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)61089-6"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00186-2"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(99)00114-0"},{"key":"e_1_2_6_32_1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1201\/b14140-26","volume-title":"Cancer Risk Assessment","author":"Linet M.S.","year":"2005"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-081018"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2508"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.06.039"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100083626"},{"key":"e_1_2_6_37_1","volume-title":"International Classification of Diseases for Oncology","author":"Percy C.","year":"1990"},{"key":"e_1_2_6_38_1","volume-title":"SEER Survival Monograph: Cancer Survival Among Adults: US. SEER Program, 1988\u20132001, Patient and Tumor Characteristics","author":"Ries L.A.G.","year":"2007"},{"key":"e_1_2_6_39_1","volume-title":"Surveillance, Epidemiology, and End Results (SEER) Program (http:\/\/www.seer.cancer.gov)","author":"SEER\u201012","year":"2007"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.26"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04834.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)02780-3"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197605000-00002"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07421.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07421.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T16:18:35Z","timestamp":1695917915000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07421.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07421.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07421.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,9]]},"assertion":[{"value":"2008-12-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}